USANA Health Sciences, Inc. (NYSE:USNA - Get Free Report) shares crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $30.39 and traded as high as $33.95. USANA Health Sciences shares last traded at $33.46, with a volume of 103,990 shares traded.
Wall Street Analysts Forecast Growth
Separately, Wall Street Zen raised shares of USANA Health Sciences from a "hold" rating to a "buy" rating in a research report on Thursday, May 22nd.
Check Out Our Latest Stock Report on USANA Health Sciences
USANA Health Sciences Trading Up 2.2%
The company has a market capitalization of $623.03 million, a PE ratio of 18.38, a price-to-earnings-growth ratio of 1.05 and a beta of 0.64. The business's 50-day simple moving average is $30.34 and its 200-day simple moving average is $30.39.
USANA Health Sciences (NYSE:USNA - Get Free Report) last posted its earnings results on Tuesday, April 22nd. The company reported $0.73 earnings per share for the quarter, beating the consensus estimate of $0.70 by $0.03. The firm had revenue of $249.54 million during the quarter, compared to analyst estimates of $243.08 million. USANA Health Sciences had a net margin of 3.98% and a return on equity of 8.94%. During the same period in the previous year, the firm earned $0.86 EPS. Sell-side analysts forecast that USANA Health Sciences, Inc. will post 2.45 EPS for the current fiscal year.
Insiders Place Their Bets
In related news, CFO G Doug Iiekking sold 4,548 shares of USANA Health Sciences stock in a transaction on Friday, May 9th. The shares were sold at an average price of $29.61, for a total value of $134,666.28. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, COO Walter Noot sold 6,291 shares of USANA Health Sciences stock in a transaction on Tuesday, May 27th. The shares were sold at an average price of $30.29, for a total transaction of $190,554.39. The disclosure for this sale can be found here. Insiders sold a total of 12,013 shares of company stock worth $360,149 in the last three months. 0.63% of the stock is owned by corporate insiders.
Institutional Investors Weigh In On USANA Health Sciences
A number of institutional investors have recently added to or reduced their stakes in USNA. Pzena Investment Management LLC boosted its stake in USANA Health Sciences by 0.7% during the 1st quarter. Pzena Investment Management LLC now owns 1,095,186 shares of the company's stock worth $29,537,000 after purchasing an additional 8,110 shares during the last quarter. Dimensional Fund Advisors LP boosted its stake in USANA Health Sciences by 7.7% during the 4th quarter. Dimensional Fund Advisors LP now owns 773,228 shares of the company's stock worth $27,751,000 after purchasing an additional 55,059 shares during the last quarter. Geode Capital Management LLC boosted its stake in USANA Health Sciences by 1.6% during the 4th quarter. Geode Capital Management LLC now owns 301,949 shares of the company's stock worth $10,839,000 after purchasing an additional 4,829 shares during the last quarter. American Century Companies Inc. boosted its stake in USANA Health Sciences by 9.2% during the 1st quarter. American Century Companies Inc. now owns 255,242 shares of the company's stock worth $6,884,000 after purchasing an additional 21,445 shares during the last quarter. Finally, Jacobs Levy Equity Management Inc. boosted its stake in USANA Health Sciences by 46.2% during the 1st quarter. Jacobs Levy Equity Management Inc. now owns 188,511 shares of the company's stock worth $5,084,000 after purchasing an additional 59,535 shares during the last quarter. Institutional investors and hedge funds own 54.25% of the company's stock.
About USANA Health Sciences
(
Get Free Report)
USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider USANA Health Sciences, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and USANA Health Sciences wasn't on the list.
While USANA Health Sciences currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
